These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9037579)

  • 1. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
    Ceballos-Baumann AO
    J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia.
    Valls-Sole J; Tolosa ES; Marti MJ; Allam N
    Clin Neuropharmacol; 1994 Jun; 17(3):229-35. PubMed ID: 9316668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Feb; 20(1):42-8. PubMed ID: 9037572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
    Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
    Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study.
    Laubis-Herrmann U; Fries K; Topka H
    Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A for patients with orofacial dystonia: prospective, observational, single-centre study.
    Ruiz-de-León-Hernández G; Díaz-Sánchez RM; Torres-Lagares D; Hernández-Pacheco E; González-Martín M; Serrera-Figallo MA
    Int J Oral Maxillofac Surg; 2018 Mar; 47(3):386-391. PubMed ID: 29208327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
    Singer C; Papapetropoulos S; Vela L
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.